Posts

Regulatory Affairs and Pharmacovigilance in Hong Kong: A Practical Guide for Pharma & Medical Device Companies

-
Regulatory Affairs and Pharmacovigilance in Hong Kong Hong Kong has a distinct pharmaceutical regulatory environment that global life science companies need to understand before entering or expanding in the market. For pharmaceutical companies, the Department of Health (DH) oversees the safety, efficacy, and quality of medicines marketed in Hong Kong. Pharmaceutical products generally require registration with the Pharmacy and Poisons Board before they can be sold or distributed. At the same time, regulatory compliance does not end with product registration. Companies must consider post-market safety surveillance, regulatory changes, product information, manufacturing documentation, import and export controls, and ongoing lifecycle obligations. This is particularly important in 2026. Hong Kong has begun implementing a phased primary evaluation pathway for certain new drug applications, with Phase 1 taking effect on March 31, 2026. For global pharmaceutical and medical device organizati...
Post a Comment
Read more

Regulatory Affairs and Pharmacovigilance Services in Colombia: A Practical Guide to Market Access and Compliance

-
Image
  Regulatory Affairs and Pharmacovigilance Services in Colombia Colombia is an important pharmaceutical and healthcare market in Latin America, with a regulatory environment centered on the Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA). For pharmaceutical, biotechnology, medical device, and healthcare companies, successful market entry requires more than preparing a technical dossier. It requires a coordinated approach to registration, regulatory compliance, product information, pharmacovigilance, and post-market obligations. INVIMA is responsible for sanitary surveillance and quality control across medicines, biological products, medical devices, cosmetics, foods, and other regulated products. For medicines and biological products, the agency provides procedures covering sanitary registration, modifications, renewals, safety monitoring, and other regulatory activities. This creates a regulatory environment in which Regulatory Affairs (RA) and Pharmaco...
Post a Comment
Read more

Regulatory Affairs and Pharmacovigilance Services in Japan: A Comprehensive Guide to Regulatory Compliance and Market Access

-
Image
Regulatory Affairs and Pharmacovigilance Services in Japan Japan is the world's third-largest pharmaceutical market and one of the most highly regulated healthcare environments. Its robust regulatory framework, advanced healthcare infrastructure, and strong emphasis on quality and patient safety make it an attractive destination for pharmaceutical, biotechnology, and medical device companies seeking global expansion. However, successfully entering and sustaining products in the Japanese market requires a thorough understanding of country-specific regulatory requirements. Companies must navigate complex approval pathways, maintain compliance with evolving regulations, ensure accurate product labeling, and establish effective pharmacovigilance systems throughout a product's lifecycle. Regulatory Affairs (RA) and Pharmacovigilance (PV) have therefore become strategic business functions rather than administrative compliance activities. These disciplines support product regist...
Post a Comment
Read more

Regulatory Affairs and Pharmacovigilance Services in the European Union: A Strategic Guide to Compliance, Market Access, and Lifecycle Management

-
Image
Regulatory Affairs and Pharmacovigilance Services in the European Union The European Union (EU) represents one of the world's most regulated and influential pharmaceutical markets, offering access to over 400 million people through a harmonized regulatory framework. While the centralized and decentralized approval pathways simplify access across Member States, pharmaceutical companies must comply with an extensive network of regulations governing product development, marketing authorization, manufacturing, pharmacovigilance, and post-market lifecycle management. The regulatory landscape continues to evolve in response to scientific innovation, digital health technologies, advanced therapies, and growing expectations for patient safety. As a result, Regulatory Affairs (RA) and Pharmacovigilance (PV) have become strategic business functions rather than administrative compliance activities. Regulatory Affairs ensures that medicinal products satisfy legal, scientific, and technic...
Post a Comment
Read more